Manila Times Business
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the "Company” or "Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that on June 1, 2026 (the "Grant Date”), Pulmonx granted equity awards under its 2025 Inducement Plan (the "Inducement Plan”) to 17 individuals hired by Pulmonx in the first two quarters of 2026. The awards were approved by the Compensation Committee of the Company’s Board of Directors and were
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Guggenheim Investments Announces June 2026 Closed-End Fund Distributions
1h ago
University of Miami Miller School of Medicine Names Dr. Pradeep Ramulu Chair of Ophthalmology and the Bascom Palmer Eye Institute
1h ago
Xometry Announces Proposed Public Offering of Class A Common Stock
1h ago
Hallador Energy Acquires 460 MW of Siemens Turbines for $350 Million, Accelerating Merom Natural Gas Generation Project
1h ago